Notify me when venBio Partners LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 6 | $216,272,926 | $0 | -$6,326,378 | -$6,326,378 | PHVS, ALMS, HRMY, ALXO, LYEL | 13F-HR | 17 Feb 2026, 16:08 |
| Q3 2025 | 6 | $176,403,556 | +$8,732,500 | $0 | +$8,732,500 | PHVS, ALMS, ALXO, HRMY, LYEL | 13F-HR | 14 Nov 2025, 16:22 |
| Q2 2025 | 6 | $114,756,634 | +$9,682,769 | -$13,298,311 | -$3,615,542 | PHVS, HRMY, ALMS, LYEL, ALXO | 13F-HR | 14 Aug 2025, 16:15 |
| Q1 2025 | 7 | $123,555,835 | $0 | -$2,622,488 | -$2,622,488 | PHVS, ALMS, HRMY, SLRN, ALXO | 13F-HR | 15 May 2025, 16:18 |
| Q4 2024 | 7 | $170,706,284 | +$4,545,402 | -$3,042,931 | +$1,502,471 | PHVS, ALMS, HRMY, ALXO, ARTV | 13F-HR | 14 Feb 2025, 16:26 |
| Q3 2024 | 6 | $194,333,956 | +$23,483,552 | -$23,404,569 | +$78,983 | PHVS, ALMS, HRMY, ARTV, SLRN | 13F-HR | 14 Nov 2024, 16:20 |
| Q2 2024 | 6 | $231,515,680 | +$37,586,438 | -$707,071 | +$36,879,367 | PHVS, ALXO, ALMS, HRMY, SLRN | 13F-HR | 14 Aug 2024, 16:12 |
| Q1 2024 | 5 | $281,883,912 | $0 | -$336,706,654 | -$336,706,654 | ALXO, PHVS, HRMY, SLRN, ELEV | 13F-HR | 15 May 2024, 16:35 |
| Q4 2023 | 7 | $667,195,408 | +$18,368,038 | -$26,353,124 | -$7,985,086 | RYZB, ALXO, PHVS, HRMY, SLRN | 13F-HR | 14 Feb 2024, 16:41 |
| Q3 2023 | 8 | $352,654,907 | +$126,137,689 | -$48,409 | +$126,089,280 | RYZB, PHVS, ALXO, SLRN, HRMY | 13F-HR | 14 Nov 2023, 16:38 |
| Q2 2023 | 7 | $276,308,116 | +$112,278,448 | -$61,493,475 | +$50,784,973 | SLRN, ALXO, PHVS, HRMY, VTYX | 13F-HR | 14 Aug 2023, 16:32 |
| Q1 2023 | 6 | $180,423,919 | $0 | -$43,808,491 | -$43,808,491 | VTYX, ALXO, HRMY, PHVS, IMPLQ | 13F-HR | 15 May 2023, 16:44 |
| Q4 2022 | 7 | $322,544,329 | $0 | -$94,284,025 | -$94,284,025 | VTYX, ALXO, HRMY, PHVS, IMPLQ | 13F-HR | 14 Feb 2023, 17:10 |
| Q3 2022 | 8 | $432,231,000 | $0 | -$77,937,132 | -$77,937,132 | VTYX, ALXO, CINC, HRMY, AKRO | 13F-HR | 14 Nov 2022, 16:36 |
| Q2 2022 | 9 | $351,225,000 | +$3,095,923 | -$17,468,098 | -$14,372,175 | ALXO, HRMY, VTYX, PHVS, CINC | 13F-HR | 15 Aug 2022, 16:59 |
| Q1 2022 | 10 | $451,083,000 | +$34,742,000 | -$58,181,735 | -$23,439,735 | ALXO, HRMY, VTYX, PHVS, CINC | 13F-HR | 16 May 2022, 16:48 |
| Q4 2021 | 9 | $555,056,000 | +$99,529,000 | -$24,872,218 | +$74,656,782 | ALXO, HRMY, VTYX, AKRO, PHVS | 13F-HR | 14 Feb 2022, 17:06 |
| Q3 2021 | 9 | $1,003,768,000 | $0 | -$42,924,979 | -$42,924,979 | ALXO, HRMY, AKRO, PHVS, IMPLQ | 13F-HR | 15 Nov 2021, 16:23 |
| Q2 2021 | 10 | $847,239,000 | +$59,817,000 | -$11,034,827 | +$48,782,173 | ALXO, HRMY, AKRO, PHVS, ELEV | 13F-HR | 16 Aug 2021, 16:43 |
| Q1 2021 | 8 | $1,052,382,000 | +$64,447,000 | -$310,703 | +$64,136,297 | ALXO, HRMY, AKRO, PHVS, CMPI | 13F-HR | 17 May 2021, 16:22 |
| Q4 2020 | 7 | $1,132,978,000 | $0 | -$8,632,665 | -$8,632,665 | ALXO, HRMY, AKRO, CMPI, APLS | 13F-HR | 16 Feb 2021, 16:46 |
| Q3 2020 | 8 | $658,029,000 | +$558,397,000 | -$32,535,803 | +$525,861,197 | ALXO, HRMY, AKRO, CMPI, MTCR | 13F-HR | 16 Nov 2020, 16:26 |
| Q2 2020 | 4 | $120,272,000 | $0 | -$21,209,038 | -$21,209,038 | AKRO, DTIL, APLS, VRNA | 13F-HR | 14 Aug 2020, 16:49 |
| Q1 2020 | 6 | $117,344,000 | $0 | -$57,853,128 | -$57,853,128 | AKRO, DTIL, APLS, TPTX, MNLO | 13F-HR | 15 May 2020, 16:16 |
| Q4 2019 | 6 | $233,252,000 | $0 | -$39,687,142 | -$39,687,142 | AKRO, DTIL, TPTX, APLS, MNLO | Restatement | 20 May 2020, 17:23 |
| Q3 2019 | 6 | $210,789,000 | $0 | $0 | $0 | AKRO, TPTX, DTIL, APLS, MNLO | Restatement | 20 May 2020, 17:22 |
| Q2 2019 | 6 | $225,356,000 | +$130,285,000 | -$13,331,931 | +$116,953,069 | AKRO, DTIL, TPTX, APLS, MNLO | Restatement | 20 May 2020, 17:22 |
| Q1 2019 | 4 | $123,479,000 | +$76,559,000 | -$5,147,544 | +$71,411,456 | DTIL, APLS, MNLO, VRNA | Restatement | 20 May 2020, 17:21 |
| Q4 2018 | 3 | $38,077,000 | $0 | $0 | $0 | APLS, VRNA, MNLO | 13F-HR | 26 May 2020, 15:56 |